TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema

A. L. Bosma, P. I. Spuls, I. Garcia-Doval, L. Naldi, D. Prieto-Merino, F. Tesch, C. J. Apfelbacher, B. W.M. Arents, S. Barbarot, E. Baselga, M. Deleuran, L. F. Eichenfield, L. A.A. Gerbens, A. D. Irvine, A. Manca, P. Mendes-Bastos, M. A. Middelkamp-Hup, A. Roberts, J. Seneschal, SvenssonJ. P. Thyssen, T. Torres, F. M. Vermeulen, C. Vestergaard, L. B. von Kobyletzki, D. Wall, S. Weidinger, J. Schmitt, C. Flohr*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

Fingerprint

Dive into the research topics of 'TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology

Pharmacology, Toxicology and Pharmaceutical Science